New patterns of relapse in multiple myeloma: a case of “light chain escape” in which FLC predicted relapse earlier than urine and serum immunofixation.
Caldini A et al. Clin Chem Lab Med. 2015 Nov 18. pii: /j/cclm.ahead-of-print/cclm-2015-0689/cclm-2015-0689.xml. doi: 10.1515/cclm-2015-0689. [Epub ahead of print].
TLR4/TIRAP polymorphisms are associated with progression and survival of patients with symptomatic myeloma.
Bagratuni T et al. Br J Haematol. 2015 Nov 13. doi: 10.1111/bjh.13786. [Epub ahead of print].
18F-FDG PET/CT Demonstrated the Multiple Myeloma From Prostate.
Cheng A et al. Clin Nucl Med. 2015 Nov 11. [Epub ahead of print].
Absence of both CD56 and CD117 expression on malignant plasma cells is related with a poor prognosis in patients with newly diagnosed multiple myeloma.
Pan Y et al. Leuk Res. 2015 Nov 4. pii: S0145-2126(15)30542-7. doi: 10.1016/j.leukres.2015.11.003. [Epub ahead of print].
Prospective study of signalling pathways in myeloma bone disease with regard to activity of the disease, extent of skeletal involvement and correlation to bone turnover markers.
Minarik J et al. Eur J Haematol. 2015 Nov 27. doi: 10.1111/ejh.12708. [Epub ahead of print]